MYC and neoplasm: Moreover, the high-risk group exhibited a significant enrichment of pathways associated with poor tumor prognosis, including “E2F targets pathway”, “G2M checkpoint pathway”, “MTORC1 signaling pathway”, “MYC targets pathway”, and “RIBOSOME” based on GSEA analysis (Figure 7I,J) [26,27,28,29,30].